Premium
Effect of mutations in the β 1 ‐thyroid hormone receptor on the inhibition of T 3 binding by desethylamiodarone
Author(s) -
van Beeren H.C.,
Bakker O.,
Chatterjee V.K.K.,
Wiersinga W.M.
Publication year - 1999
Publication title -
febs letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.593
H-Index - 257
eISSN - 1873-3468
pISSN - 0014-5793
DOI - 10.1016/s0014-5793(99)00453-6
Subject(s) - mutant , triiodothyronine , chemistry , amino acid , binding site , non competitive inhibition , receptor , wild type , competitive binding , ic50 , stereochemistry , biochemistry , hormone , in vitro , enzyme , gene
Desethylamiodarone (DEA) acts as a competitive inhibitor of triiodothyronine (T 3 ) binding to the α 1 ‐thyroid hormone receptor (TRα 1 ) but as a non‐competitive inhibitor with respect to TRβ 1 . To gain insight into the position of the binding site of desethylamiodarone on TRβ 1 we investigated the naturally occurring mutants Y321C, R429Q, P453A, P453T and the artificial mutants L421R and E457A in the ligand binding domain of human TRβ 1 . The IC 50 values (in μM) of DEA for P453A (50±11) and P453T (55±16) mutant TRβ 1 are not different from that for the wild type TRβ 1 (56±15), but the IC 50 values of R429Q (32±7; P <0.001) and E457A (17±3; P <0.001) are significantly lower than of the wild type. Scatchard plots and Langmuir analyses indicate a non‐competitive nature of the inhibition by DEA of T 3 binding to all four mutant TRβ 1 s tested. Mutants P453A and P453T do not influence overall electrostatic potential, and also do not influence the affinity for DEA compared to wild type. Mutant E457A causes a change from a negatively charged amino acid to a hydrophobic amino acid, enhancing the affinity for DEA. Mutant R429Q, located in helix 11, causes an electrostatic potential change from positive to uncharged, also resulting in greater affinity for DEA. We therefore postulate that amino acids R429 and E457 are at or close to the binding site for DEA, and that DEA does not bind in the T 3 binding pocket itself, in line with the non‐competitive nature of the inhibition of T 3 binding to TRβ 1 by DEA.